There are several reasons biotechnology stocks are an investor favorite. One of those reasons is that this is a vast sector. Here, companies great and small develop the next generation of treatments and medical advancements that cover everything from chronic illness to cosmetic enhancements. As such, no two companies are ever the same, and investors are afforded a lot of choices.
However, this is a risky sector. For example, many small-cap companies will never receive FDA approval for a drug. The majority of treatments entering clinical trials are thrown in the bin by regulators, and it’s ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.